Litigation Details for CVS Pharmacy, Inc v. Gilead Sciences, Inc. (N.D. Cal. 2021)

✉ Email this page to a colleague

Docket	⤷ Sign Up	Date Filed	2021-09-22
Court	District Court, N.D. California	Date Terminated
Cause	15:1 Antitrust Litigation	Assigned To	Edward Milton Chen
Jury Demand	Plaintiff	Referred To
Patents	6,043,230; 6,639,071; 6,642,245; 6,703,396; 8,592,397; 8,716,264; 9,457,036
Link to Docket	External link to docket

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .

The biologic drug covered by the patents cited in this case is ⤷ Sign Up .

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
2021-09-22	1	Complaint	5,977,089 (“the ‘089 Patent”), and 6,043,230 (“the ‘230 Patent”). These three 5 patents all derive from the… the TDF Patents 4 (the ‘695 patent, the ‘089 patent, the ‘230 patent, and the ‘946 patent), which …Gilead’s Viread patent portfolio consists of U.S. Patents Nos. 5,922,695 (“the 4 ‘695 Patent”), 5,977,089… (“the ‘245 patent”) and 6,703,396 (“the ‘396 patent”) 3 (collectively “the FTC Patents”). Truvada … invalid. 13 These patents include U.S. Patent Nos. 8,592,397 (“the ‘397 patent”), 8,716,264 (“the ‘	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document